Protected by Patent-Linkage System, door of ‘Micardis Plus’ generic market opens
Domestic medium pharmaceutical companies have succeeded in avoiding the formulation patent of Micardis Plus(Boehringer Ingelheim), an antihypertensive complex.
The patent has been an obstacle for its generics to enter the market after the enforcement of the Patent-Linkage System last year.
Acco...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
